(MENAFN- AzerNews) By Trend
Uzbekistan's Namangan city is closing borders for all modes of transport due to the coronavirus outbreak, Trend reports via Uzbek media.
"From March 26, entry and exit from Namangan will be closed for all types of transport, including buses, cars, air and rail transport," the message said.
Restrictions on entry and exit from Namangan do not apply to freight transport. Only citizens, permanently residing (registered) in Namangan city, as well as heads and staff of state authorities, law enforcement agencies, departments and organizations (NGOs), doctors and nurses, employees of the State Sanitary and Epidemiological Surveillance from the regions, working in Namangan, as well as responsible persons assigned to the districts by a separate order of the regional mayor.
The first case of Coronavirus infection in Uzbekistan was detected on March 15 in the laboratory of the Research Institute of Virology - an Uzbek woman, returning from France, tested coronavirus-positive. The Ministry of Health later said that her son, daughter, husband and grandson also tested coronavirus-positive.
The number of people infected with coronavirus in Uzbekistan is 60.
The outbreak in the Chinese city of Wuhan - which is an international transport hub - began at a fish market in late December 2019. The number of people killed by the disease has surpassed 21,300. Over 471,000 people have been confirmed as infected. Meanwhile, over 114,800 people have reportedly recovered.
Some sources claim the coronavirus outbreak started as early as November 2019. Several countries are working on a vaccine against the new virus.
The World Health Organization (WHO) on March 11 declared COVID-19 a pandemic.
Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.